Cover Image

Positivity of high‐sensitivity HBsAg test, not previous HBV infection, indicates poor prognosis in patients with non‐HBV‐related HCC

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Naohiro Yasuura, Goki Suda, Masatsugu Ohara, Akimitsu Meno, Takuya Sho, Risako Kohya, Takashi Sasaki, Tomoka Yoda, Sonoe Yoshida, Qingjie Fu, Zijian Yang, Shunichi Hosoda, Osamu Maehara, Shunsuke Ohnishi, Tomoya Saitou, Masaya Sugiyama, Takasuke Fukuhara, Masaru Baba, Takashi Kitagataya, Naoki Kawagishi, Masato Nakai, Mitsuteru Natsuizaka, Koji Ogawa, Akinobu Taketomi, Naoya Sakamoto
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Alimentary Pharmacology & Therapeutics
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prevalence and Prognostic Impact of the Coexistence of Cachexia and Sarcopenia in Patients With Chronic Liver Diseases
by: Takatsugu Tanaka, et al.
Published: (2026)

Association of proteinuria with improved prognosis in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab, and the predictive role of serum vascular endothelial growth factor D levels: A multicenter retrospective study
by: Zijian Yang, et al.
Published: (2024)

Measuring HBV pregenomic RNA may be a potential biomarker to determine HBV functional cure in HIV/HBV‐co‐infected patients with HBsAg loss
by: Fei Gu, et al.
Published: (2024)

Analysis of HBV Genome Integration in Patients With HBV‐Previously Infected NBNC‐HCC
by: Tomoya Saito, et al.
Published: (2026)

Hepatic Flare Following Effective Antiretroviral Therapy Is Associated With HBsAg Seroclearance in HBV/HIV‐1 Co‐Infection
by: Weiyin Lin, et al.
Published: (2024)

Letter: Positivity of High‐Sensitivity HBsAg Test Was Significantly Associated With Poor Prognosis in Patients With Non‐HBV‐Related HCC
by: Xiaosong Li, et al.
Published: (2024)

TNF‐α Inhibitors and HBV Reactivation Risk in HBsAg−/Anti‐HBc+ Patients: A Systematic Review and Meta‐Analysis
by: Meng Hsuan Kuo, et al.
Published: (2026)

What is the real sword of HBV precore and basal core promoter mutations piercing the hepatocyte homeostasis: HBcAg or HBsAg?
by: Guixin Li, et al.
Published: (2024)

scRNA ‐Seq Reveals Sustained Pro‐Inflammation by Innate Immune Activation in In Utero HBV‐ Exposed Neonates of High HBsAg Mothers
by: Prabhjyoti Pahwa, et al.
Published: (2025)

What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg‐negative anti‐HBc‐positive patients? Meta‐analysis and decision curve analysis
by: Ciro Celsa, et al.
Published: (2024)

Infectivity of Hepatitis B Virus Surface Antigen‐Positive Plasma With Undetectable HBV‐DNA: Can HBsAg Screening Be Discontinued in Egyptian Blood Donors?
by: Magdy El Ekiaby, et al.
Published: (2024)

Incidence and Characteristics of HBV Reactivation‐Related Events Following HBsAg Seroclearance: Long‐Term Follow‐up of a Population‐Based Cohort in Japan
by: Kazumi Yamasaki, et al.
Published: (2026)

Clinical performance of Circulating HBV RNA and iTACT‐HBcrAg Assays in HBeAg‐negative and HBsAg‐cleared Chronic Hepatitis B Patients
by: Takanori Suzuki, et al.
Published: (2024)

Letter: Using Anti‐ HBs Titres to Tailor HBV Reactivation Monitoring in Patients With Solid Tumours
by: Tsutomu Nishida, et al.
Published: (2026)

Evaluation of HBsAg and Anti‐HBs Coexistence: Authenticity and Contributing Factors
by: Hao Xu, et al.
Published: (2026)

HBV And HCV Molecular Evolution
by: FLOR H. PUJOL
Published: (2007)

Occult HBV infection and HCC
by: ISABELLE CHEMIN
Published: (2007)

Dynamics of Circulatory HBcrAg and HBsAg After Nucleos(t)ide Analogue Cessation Using iTACT Assays to Predict Clinical Flares and HBsAg Loss
by: Ying‐Nan Tsai, et al.
Published: (2026)

Global elimination of HBV: Is it really achievable?
by: Erwan Vo‐Quang, et al.
Published: (2024)

The immune response in chronic HBV infection
by: Antonio Bertoletti
Published: (2024)

Animal models for HCV and HBV studies
by: ISABELLE CHEMIN
Published: (2007)

The Effect of HBV Therapy on Glycemic Control in HBV‐Infected Patients With Diabetes: A 90‐day Multicenter Study
by: Qi Liu, et al.
Published: (2025)

Clinical and Histopathological Correlation of Quantitative HBsAg Levels in Chronic Hepatitis B
by: Turgay Yılmaz, et al.
Published: (2025)

Unaddressed Methodological Heterogeneities in the Assessment of HCC Risk After HBsAg Seroclearance
by: Sen Tao, et al.
Published: (2025)

Editorial: HBV Integration: A Possible Key Driver in the Course of Patients With Chronic HBV Infection Under Viral Suppression
by: Hidenori Toyoda
Published: (2025)

Association of HBV serological markers with host antiviral immune response relevant hepatic inflammatory damage in chronic HBV infection
by: Bei Jiang, et al.
Published: (2024)

Urethral Reconstruction for Hypospadias Repair Using an Ulnar Forearm Flap: A Report of Long‐Term Outcomes of 3 Cases
by: Goki Ohashi, et al.
Published: (2025)

Coinfección HBV-HCV y HIV-HCV
by: Fernando Bessone
Published: (2005)

Epigenetic Modifications in HBV‐Related Hepatocellular Carcinoma
by: Xiaoqing Tan, et al.
Published: (2025)

Letter: No Biochemical Relapse Is Associated With the Highest Off‐Therapy HBsAg Loss Rate
by: Wen‐Juei Jeng, et al.
Published: (2025)

Discovery and mechanistic study of Imperatorin that inhibits HBsAg expression and cccDNA transcription
by: Fang Ren, et al.
Published: (2024)

Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy–Induced HBsAg Seroclearance
by: Han Ah. Lee, et al.
Published: (2025)

Clinical Observational Study on HBV Reactivation After Direct‐Acting Antiviral Therapy in HCV / HBV Coinfected Patients in Guizhou, China
by: Mei Wang, et al.
Published: (2025)

Extrathymic CD8 and CD4 Double Positive T Cells Presenting Vigorous HBV‐Specific Responses Accelerate HBV Clearance
by: Zhong Fang, et al.
Published: (2025)

Misuse of the Lower Limit of Detection in HBV DNA Testing and Anti‐HBe Positive Status Will Significantly Impact the Diagnosis of Occult HBV Infection
by: Bo Wang, et al.
Published: (2024)

HBV Recurrence Detected by HBV‐Related Serum Markers and Immune Escape Mutations in Chronic Hepatitis B Patients Following Liver Transplantation
by: Chien‐Ming Chiang, et al.
Published: (2025)

Editorial: HBV Integration—A Possible Key Driver on the Course of Patients With Chronic HBV Infection Under Viral Suppression. Authors' Reply
by: Qin Ning, et al.
Published: (2025)

Editorial: Ultralow HBsAg Levels and the Prediction of Cure in Chronic Hepatitis B—Authors' Reply
by: Jian Wang, et al.
Published: (2025)

Estabilidad de HBsAg en muestras de sangre seca sobre papel filtro
by: Aurora Delahanty Fernández
Published: (2002)

A Comparative Study of Entecavir and Tenofovir Alafenamide on Quantitative HBsAg Reduction in Patients With CHB
by: Jungnam Lee, et al.
Published: (2026)